Pacific Hospital Supply Co., Ltd.(TW:4126)
NT$75.00+0.70 (+0.94%)
TW:4126
Pacific Hospital Supply Co., Ltd. financials statements
NT$75.00
At close:+0.70 (+0.94%)
Pacific Hospital Supply Co., Ltd. (4126) Ratios
Pacific Hospital Supply Co., Ltd. Ratios
TW:4126's free cash flow for Q2 2026 was NT$167.81M. For the 2026 fiscal year, TW:4126's free cash flow was decreased by NT$-18.12M and operating cash flow was NT$185.93M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.49 | 3.40 | 3.03 | 2.64 | 3.22 |
| Quick Ratio | 2.75 | 2.74 | 2.36 | 1.91 | 2.43 |
| Cash Ratio | 1.58 | 1.43 | 1.45 | 1.37 | 1.92 |
| Solvency Ratio | 0.55 | 0.62 | 0.60 | 0.52 | 0.50 |
| Operating Cash Flow Ratio | 1.04 | 0.98 | 1.27 | 0.86 | 0.75 |
| Short-Term Operating Cash Flow Coverage | 123.83 | 113.79 | 220.08 | 172.11 | 125.44 |
| Net Current Asset Value | NT$ 870.68M | NT$ 814.42M | NT$ 623.31M | NT$ 395.98M | NT$ 275.05M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.11 | 0.11 | 0.12 | 0.12 | 0.18 |
| Debt-to-Equity Ratio | 0.15 | 0.15 | 0.15 | 0.16 | 0.25 |
| Debt-to-Capital Ratio | 0.13 | 0.13 | 0.13 | 0.14 | 0.20 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.08 |
| Financial Leverage Ratio | 1.32 | 1.32 | 1.33 | 1.34 | 1.40 |
| Debt Service Coverage Ratio | 50.18 | 53.71 | 65.41 | 51.00 | 49.78 |
| Interest Coverage Ratio | 79.53 | 74.79 | 86.90 | 59.81 | 51.41 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 |
| Interest Debt Per Share | 6.04 | 6.05 | 6.11 | 6.15 | 9.43 |
| Net Debt to EBITDA | -0.64 | -0.44 | -0.46 | -0.44 | -0.23 |
| Profitability Margins | |||||
| Gross Profit Margin | 30.12% | 31.84% | 31.88% | 26.91% | 25.93% |
| EBIT Margin | 19.68% | 24.02% | 22.90% | 19.25% | 21.93% |
| EBITDA Margin | 25.44% | 29.81% | 29.04% | 26.02% | 29.86% |
| Operating Profit Margin | 19.68% | 20.88% | 21.46% | 19.25% | 21.93% |
| Pretax Profit Margin | 19.81% | 23.74% | 22.65% | 18.92% | 21.50% |
| Net Profit Margin | 15.91% | 19.10% | 18.14% | 15.17% | 19.14% |
| Continuous Operations Profit Margin | 15.91% | 19.10% | 18.14% | 15.17% | 19.14% |
| Net Income Per EBT | 80.35% | 80.43% | 80.08% | 80.15% | 89.03% |
| EBT Per EBIT | 100.63% | 113.69% | 105.52% | 98.33% | 98.05% |
| Return on Assets (ROA) | 9.77% | 11.54% | 11.17% | 9.09% | 10.18% |
| Return on Equity (ROE) | 12.90% | 15.22% | 14.85% | 12.20% | 14.28% |
| Return on Capital Employed (ROCE) | 13.94% | 14.55% | 15.31% | 13.38% | 13.13% |
| Return on Invested Capital (ROIC) | 11.15% | 11.65% | 12.19% | 10.67% | 11.64% |
| Return on Tangible Assets | 9.79% | 11.56% | 11.18% | 9.10% | 10.19% |
| Earnings Yield | 6.19% | 6.32% | 6.71% | 6.05% | 7.09% |
| Efficiency Ratios | |||||
| Receivables Turnover | 10.14 | 8.33 | 11.53 | 8.98 | 10.75 |
| Payables Turnover | 9.84 | 8.53 | 9.24 | 7.86 | 8.95 |
| Inventory Turnover | 4.36 | 4.73 | 4.60 | 4.35 | 4.46 |
| Fixed Asset Turnover | 1.19 | 1.19 | 1.12 | 1.00 | 0.88 |
| Asset Turnover | 0.61 | 0.60 | 0.62 | 0.60 | 0.53 |
| Working Capital Turnover Ratio | 1.90 | 2.06 | 2.49 | 2.48 | 2.27 |
| Cash Conversion Cycle | 82.52 | 78.26 | 71.55 | 77.99 | 75.00 |
| Days of Sales Outstanding | 35.99 | 43.84 | 31.65 | 40.63 | 33.96 |
| Days of Inventory Outstanding | 83.65 | 77.22 | 79.40 | 83.82 | 81.83 |
| Days of Payables Outstanding | 37.11 | 42.80 | 39.50 | 46.46 | 40.78 |
| Operating Cycle | 119.64 | 121.06 | 111.05 | 124.45 | 115.79 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 7.47 | 6.96 | 9.01 | 5.95 | 4.40 |
| Free Cash Flow Per Share | 6.44 | 6.29 | 8.56 | 5.43 | 3.93 |
| Dividend Paid and CapEx Coverage Ratio | 1.24 | 1.27 | 1.93 | 1.19 | 0.94 |
| Capital Expenditure Coverage Ratio | 7.30 | 10.38 | 19.86 | 11.51 | 9.39 |
| Operating Cash Flow Coverage Ratio | 1.25 | 1.17 | 1.49 | 0.98 | 0.47 |
| Operating Cash Flow to Sales Ratio | 0.23 | 0.22 | 0.28 | 0.20 | 0.16 |
| Free Cash Flow Yield | 7.56% | 6.44% | 9.90% | 7.19% | 5.23% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 16.17 | 15.82 | 14.90 | 16.56 | 14.12 |
| Price-to-Sales (P/S) Ratio | 2.57 | 3.02 | 2.70 | 2.51 | 2.70 |
| Price-to-Book (P/B) Ratio | 2.08 | 2.41 | 2.21 | 2.02 | 2.02 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 13.22 | 15.52 | 10.10 | 13.91 | 19.12 |
| Price-to-Operating Cash Flow Ratio | 11.41 | 14.02 | 9.59 | 12.70 | 17.09 |
| Price-to-Earnings Growth (PEG) Ratio | -1.11 | 2.48 | 0.55 | -1.16 | 0.81 |
| Enterprise Value Multiple | 9.46 | 9.69 | 8.85 | 9.20 | 8.81 |
| Enterprise Value | 5.79B | 6.78B | 5.96B | 5.23B | 5.31B |
| EV to EBITDA | 9.46 | 9.69 | 8.85 | 9.20 | 8.81 |
| EV to Sales | 2.41 | 2.89 | 2.57 | 2.39 | 2.63 |
| EV to Free Cash Flow | 12.38 | 14.84 | 9.60 | 13.28 | 18.63 |
| EV to Operating Cash Flow | 10.68 | 13.41 | 9.12 | 12.12 | 16.65 |
| Tangible Book Value Per Share | 40.78 | 40.45 | 38.99 | 37.34 | 37.21 |
| Shareholders’ Equity Per Share | 40.87 | 40.54 | 39.06 | 37.42 | 37.27 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.20 | 0.20 | 0.20 | 0.20 | 0.11 |
| Revenue Per Share | 33.14 | 32.31 | 31.98 | 30.10 | 27.81 |
| Net Income Per Share | 5.27 | 6.17 | 5.80 | 4.56 | 5.32 |
| Tax Burden | 0.80 | 0.80 | 0.80 | 0.80 | 0.89 |
| Interest Burden | 1.01 | 0.99 | 0.99 | 0.98 | 0.98 |
| Research & Development to Revenue | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 |
| SG&A to Revenue | 0.07 | 0.08 | 0.08 | 0.09 | 0.08 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.42 | 0.91 | 1.24 | 1.04 | 0.74 |
Currency in TWD
